-
Sun Pharma Share Price: 17.4% CAGR in 3 Years as the Sector Heavyweight Faces Cipla and Divi’s Labs
- November 11, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
No Comments
Sun Pharma share price compounded at 17.4% a year over 3 years. See how it compares with Cipla and Divi’s Laboratories on returns and ROE.
-
Sun Pharma Q2 FY27 Results: Net Profit Falls 36% to Rs 1,989 Crore on Rs 1,269 Crore One-Time Charges, While Adjusted Profit Rises 1.4% and Revenue Climbs 12%
- November 2, 2026
- Posted by: Kunal Singla
- Category: Results
Sun Pharma Q2 results: profit fell 36% to Rs 1,989 crore on one-time charges, but adjusted profit rose 1.4% and revenue 12%. India strong, US weak. Share price and what to watch.
-
F&O Stocks to Buy: CDSL, Zydus Lifesciences and Sun Pharma on Jay Thakkar’s Near-Term List, With Price Levels, Technicals and Risks
- October 28, 2026
- Posted by: Harsh Piplani
- Category: News
F&O stocks to buy named by Jay Thakkar: CDSL, Zydus Lifesciences and Sun Pharma. See price levels, technicals, fundamentals and risks, and why range-bound markets matter.
-
Sun Pharma results Q2FY23
- November 4, 2022
- Posted by: Sheen Hitaishi
- Category: Market
-
Sun Pharma Q1FY23 Result reports a robust performance
- August 2, 2022
- Posted by: Avneet Dhamija
- Category: Market